Ferritin Light Chain Monoclonal Antibody, Cy7 Conjugated
Applications
Reactivity
| Overview | |
| Catalog # | bsm-41189m-cy7-100ul |
| Product Name | Ferritin Light Chain Monoclonal Antibody, Cy7 Conjugated |
| Applications | WB |
| Reactivity | Human |
| Specifications | |
| Conjugation | Cy7 |
| Host | Mouse |
| Clonality | Monoclonal |
| Clone # | 1E4 |
| Isotype | IgG |
| Concentration | 1ug/ul |
| Purification | Purified by Protein A. |
| Storage Buffer | Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles. |
| Target | |
| Gene ID | 2512 |
| Swiss Prot | P02792 |
| Subcellular location | Cytoplasm, Secreted, Extracellular matrix |
| Synonyms | Ferritin light polypeptide; Ferritin L chain; Ferritin L subunit; Ferritin light chain; Ferritin light polypeptide like 3; FRIL; FRIL_HUMAN; FTL; L apoferritin; MGC71996; NBIA 3; NBIA3 |
| Background | Oligomer of 24 subunits. There are two types of subunits: L (light) chain and H (heavy) chain. The major chain can be light or heavy, depending on the species and tissue type. The functional molecule forms a roughly spherical shell with a diameter of 12 nm and contains a central cavity into which the insoluble mineral iron core is deposited. Iron enters the spherical protein shell through pores that are formed between subunits. Mutations leading to truncation or the addition of extra residues at the C-terminus interfere with normal pore formation and with iron accumulation. |
| Application Dilution | |
| WB | 1:500-2000 |
Powered by Bioz